News
Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron.
Interventional cardiologists share insights into the progress of procedures and devices such as Impella and TAVI for acute ...
According to the Ministry of Health and Family Welfare, the number of active cases increased by 276 in the last 24 hours, ...
SGMC Health has successfully performed its first procedure using the Abiomed Impella 5.5 with SmartAssist, a minimally ...
18d
MyChesCo on MSNWindtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major ConferenceWARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has unveiled new data on istaroxime, a treatment candidate for cardiogenic shock, at the European Society of Cardiology Heart Failure 2025 ...
Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the ...
Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.
Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates
Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.
According to reports, his death was caused by cardiogenic shock as a result of an acute myocardial infarction, or a severe heart attack. The reports further confirmed that the actor has been ...
Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, pharmacological therapies, AI, and telemedicine. Discover how these ...
Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results